New genome-editing technologies support to advance cancer research and treatment
Official title: Development of New Technologies at Roswell Park to Further Cancer-Based Research and Treatment Through Genome Modification
Funded at Roswell Park Cancer Institute Corp · NIH-11397798 · Data updated 2026-11-12
A cancer center grant funds salary support for a gene editing expert who helps researchers use genome editing tools to study and treat cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $324,868 |
| NIH project number | 5R50CA283761-04 |
| Project ID | NIH-11397798 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with cancer whose tumors might be studied or targeted using genome editing approaches via future translational research.
✕Less likely to help
This grant does not directly enroll patients or fund a patient-facing trial.
What this research studies
This grant provides salary support for the GeTT director at Roswell Park to oversee genome editing platforms and collaborate with cancer researchers. It highlights years of experience in creating genetically modified animals and cells and guiding NIH-funded projects within the center. The goal is to ensure researchers can efficiently apply genome-targeting technologies to understand cancer biology and develop new treatments. The focus is on enabling collaborations and consultations across multiple cancer research programs housed at the center.
Why it matters
Potential benefit: If successful, the work could streamline genome editing approaches that support cancer research and potentially accelerate development of targeted therapies.
How similar studies have gone: Genome editing resources and specialized cores have supported NIH-funded cancer research and collaborations for many years.
Where this research is happening
-
Roswell Park Cancer Institute Corp
Buffalo, United States Active
Researchers
- Principal investigator: Stablewski, Aimee B — Roswell Park Cancer Institute Corp
- Study coordinator: Stablewski, Aimee B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.